查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1317884

高度活躍的醫藥原料市場：按合成、按用途- 2023-2030 年全球預測

High Potency Active Pharmaceutical Ingredients Market by Synthesis, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球高活性原料藥市場預計2023年將大幅成長至318.6億美元，複合年成長率為13.84%，預計到2030年將達到驚人的793億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球高活性藥物成分市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球高活性原料藥市場規模及預測為何？

2. 在預測期內，COVID-19 對全球高活性藥物成分市場的阻礙因素與影響有哪些？

3. 預測期內全球高活性醫藥原料市場需要投資哪些產品/細分市場/應用/領域？

4.全球高活性原料藥市場的競爭策略為何？

5. 全球高活性原料藥市場的技術趨勢和法律規範是什麼？

6.全球高活性原料藥市場主要供應商的市佔率是多少？

7. 哪些型態和策略措施被認為適合進入全球高活性原料藥市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 製藥和 CDMO 產業在全球持續擴張
      • 對藥物研發和開發的大量投資
      • 領域對標靶藥物的需求不斷增加
    • 抑制因素
      • 為 HPAPI 製造開發安全環境相關的成本很高
    • 機會
      • 政府對新分子實體的有利批准
      • 持續進行新 HPAPI 開發的研發活動 (R&D)
    • 任務
      • 與高效 API 的細胞毒性有關的擔憂
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 活躍

  • 生技原料藥
  • 合成API

第7章 活躍：依用途

  • 青光眼
  • 荷爾蒙失衡
  • 腫瘤學

第8章 北美、南美原料藥市場高度活躍

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區醫藥原料藥市場高度活躍

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東、非洲原料藥市場高度活躍

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第12章上市公司名單

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-BD19B94C9E0E

The Global High Potency Active Pharmaceutical Ingredients Market is forecasted to grow significantly, with a projected USD 31.86 billion in 2023 at a CAGR of 13.84% and expected to reach a staggering USD 79.30 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global High Potency Active Pharmaceutical Ingredients Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global High Potency Active Pharmaceutical Ingredients Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Synthesis, market is studied across Biotech API and Synthetic API. The Biotech API is projected to witness significant market share during forecast period.

Based on Application, market is studied across Glaucoma, Hormonal Imbalance, and Oncology. The Hormonal Imbalance is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global High Potency Active Pharmaceutical Ingredients Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global High Potency Active Pharmaceutical Ingredients Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global High Potency Active Pharmaceutical Ingredients Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global High Potency Active Pharmaceutical Ingredients Market?

4. What is the competitive strategic window for opportunities in the Global High Potency Active Pharmaceutical Ingredients Market?

5. What are the technology trends and regulatory frameworks in the Global High Potency Active Pharmaceutical Ingredients Market?

6. What is the market share of the leading vendors in the Global High Potency Active Pharmaceutical Ingredients Market?

7. What modes and strategic moves are considered suitable for entering the Global High Potency Active Pharmaceutical Ingredients Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. High Potency Active Pharmaceutical Ingredients Market, by Synthesis, 2022 vs 2030
  • 4.3. High Potency Active Pharmaceutical Ingredients Market, by Application, 2022 vs 2030
  • 4.4. High Potency Active Pharmaceutical Ingredients Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Ongoing expansion of pharmaceutical and CDMO industries across the globe
      • 5.1.1.2. Significant investments in drug discovery and development
      • 5.1.1.3. Rising requirement for targeted medicines by the oncology sector
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with development of safe environment for manufacturing HPAPI
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable governmental approvals for new molecular entities
      • 5.1.3.2. Ongoing research and development activities (R&D) for development of novel HPAPI
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with cytotoxic nature of high potency APIs
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. High Potency Active Pharmaceutical Ingredients Market, by Synthesis

  • 6.1. Introduction
  • 6.2. Biotech API
  • 6.3. Synthetic API

7. High Potency Active Pharmaceutical Ingredients Market, by Application

  • 7.1. Introduction
  • 7.2. Glaucoma
  • 7.3. Hormonal Imbalance
  • 7.4. Oncology

8. Americas High Potency Active Pharmaceutical Ingredients Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa High Potency Active Pharmaceutical Ingredients Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2022 VS 2030 (%)
  • FIGURE 5. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET DYNAMICS
  • FIGURE 8. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 5. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH API, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC API, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY HORMONAL IMBALANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 98. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 99. HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET LICENSE & PRICING